LATRONICO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.373
AS - Asia 1.649
EU - Europa 1.234
SA - Sud America 415
AF - Africa 108
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.788
Nazione #
US - Stati Uniti d'America 3.298
SG - Singapore 652
CN - Cina 415
BR - Brasile 333
IT - Italia 305
HK - Hong Kong 210
SE - Svezia 195
RU - Federazione Russa 137
DE - Germania 135
FR - Francia 111
VN - Vietnam 106
FI - Finlandia 87
UA - Ucraina 71
GB - Regno Unito 69
CI - Costa d'Avorio 55
IN - India 54
BD - Bangladesh 46
CA - Canada 43
AR - Argentina 25
IQ - Iraq 20
BE - Belgio 19
NL - Olanda 19
PK - Pakistan 19
TR - Turchia 19
PL - Polonia 18
ID - Indonesia 16
ZA - Sudafrica 16
CO - Colombia 15
VE - Venezuela 15
MX - Messico 14
JP - Giappone 13
AT - Austria 12
ES - Italia 11
PH - Filippine 11
IE - Irlanda 10
EC - Ecuador 9
MA - Marocco 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
LT - Lituania 8
AU - Australia 7
JO - Giordania 7
UZ - Uzbekistan 7
CL - Cile 6
DZ - Algeria 6
ET - Etiopia 6
TN - Tunisia 6
OM - Oman 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
MY - Malesia 4
PS - Palestinian Territory 4
BO - Bolivia 3
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MW - Malawi 1
SY - Repubblica araba siriana 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 6.788
Città #
Ashburn 378
Singapore 318
San Jose 307
Woodbridge 264
Chandler 258
Fairfield 214
Hong Kong 205
Houston 169
Nyköping 160
Jacksonville 145
Ann Arbor 143
Beijing 127
Wilmington 100
Seattle 90
Cambridge 85
Bari 82
New York 74
Abidjan 55
Lauterbourg 54
Lawrence 49
Roxbury 47
Boardman 46
Los Angeles 42
Ho Chi Minh City 39
Nanjing 37
Dallas 35
Marseille 35
Council Bluffs 31
São Paulo 29
Des Moines 26
Helsinki 26
Munich 26
Falkenstein 22
Brooklyn 21
Turku 21
Hanoi 20
Santa Clara 20
Chicago 19
Brussels 17
Jiaxing 16
Rio de Janeiro 16
Moscow 15
Spongano 15
Buffalo 14
Warsaw 14
Denver 13
Guangzhou 13
Jakarta 13
Leverano 13
Princeton 13
Toronto 13
Baghdad 12
Inglewood 12
Montreal 12
Wuhan 12
Amsterdam 11
Changsha 11
Falls Church 11
Grottaglie 11
London 11
Rome 11
San Diego 11
Atlanta 10
Dublin 10
Nuremberg 10
Orem 10
Paris 10
San Francisco 10
Shenyang 10
Vienna 10
Chennai 9
Frankfurt am Main 9
Milan 9
Porto Alegre 9
Shanghai 9
Da Nang 8
Hebei 8
Palermo 8
Tianjin 8
Tokyo 8
Amman 7
Auburn Hills 7
Caracas 7
Nanchang 7
Salvador 7
Addis Ababa 6
Belo Horizonte 6
Boston 6
Johannesburg 6
Phoenix 6
Piscataway 6
Tashkent 6
Washington 6
Adelfia 5
Algiers 5
Brno 5
Dhaka 5
Giovinazzo 5
Haiphong 5
Juiz de Fora 5
Totale 4.412
Nome #
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 253
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 194
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 183
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 174
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 172
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 155
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 152
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 146
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 140
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 137
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 131
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 129
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 127
High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: Insights on the size and porosity control mechanisms 125
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 124
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 115
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 110
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies 108
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 107
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 104
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 104
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 103
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 102
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 101
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 100
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 99
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 99
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 98
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 98
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 94
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 93
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 93
null 91
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 90
null 90
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 90
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 90
null 87
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 85
DEVELOPMENTAL OMEGA-3 SUPPLEMENTATION IMPROVES MOTOR SKILLS IN JUVENILE RATS 85
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 84
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 84
Differential Modulation of NF-κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules 83
Matrix Metalloproteinases in CNS Inflammation. 83
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 83
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 80
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 79
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 79
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii 75
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality 74
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 69
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19 68
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 67
Unravelling the relevance of fad synthetase in human physiopathology. A biotechnological approach. 66
Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves 61
Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 60
Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an “In Vivo” Model of Neurotoxicity 60
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation 60
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 59
Intra- and interspecific variation in electrophoretic profiles of Tethya spp.: an integration to morfological classification system 56
Interferon-alpha/beta treatment inhibits metalloproteinase activity in rat astrocyte cell cultures 55
Interferon-Beta Treatment Inhibits Matrix metalloproteinases in rat glial cell cultures 54
Use of a commercial feed supplement based on diatom earth and yeast products on oxidative status and in vitro immune response in buffaloes during peripartum 53
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia 52
Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox" 52
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects 52
Inhibition of calpain activity and expression by interferon-beta in rat astrocytes: implications for MS pathogenesis and treatment. 52
Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species 52
null 47
Lead exposure of rats during and after pregnancy induces anti-myelin proteolytic activity: a potential mechanism for lead-induced neurotoxicity 42
Inhibitory effect of immunomodulatory and immunosuppressive therapies on the activity of gelatinases and urokinase-type plasminogen activator in peripheral blood mononuclear cells from patients with multiple sclerosis 40
Enhancing Antioxidants Performance of Ceria Nanoparticles in Biological Environment via Surface Engineering with o-Quinone Functionalities 35
Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with Breast Cancer 31
Molecular mechanisms of cell toxicity and Matrix Metalloproteinase-9 inhibition by Antiretroviral Drugs in Cultured Primary Astrocytes. 30
Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients: A Pilot Study 26
Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives 26
Increased Antioxidant Performance of Lignin by Biodegradation Obtained from an Extract of the Mushroom Pleurotus eryngii 25
null 18
null 15
Hydrolytic Enzymes in the Secretome of the Mushrooms P. eryngii and P. ostreatus: A Comparison Between the Two Species 5
Totale 6.970
Categoria #
all - tutte 27.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022373 10 51 2 5 19 24 12 20 49 29 54 98
2022/2023752 77 79 53 68 86 96 9 91 131 33 15 14
2023/2024281 17 49 13 60 23 63 4 2 5 11 6 28
2024/20251.254 111 29 72 34 44 72 158 95 54 70 167 348
2025/20262.681 377 160 173 263 308 146 257 77 439 291 151 39
Totale 6.970